Vialwise
EN

Melanotan II

Melanotan II is a synthetic, ring-shaped peptide based on alpha-MSH, the hormone that tells skin to make pigment. It acts on several melanocortin receptors, so besides tanning it can cause erections, nausea and loss of appetite. It was never approved as a medicine anywhere. It is sold illegally as tanning injections and nasal sprays.

Not approved · research onlyWADA Not named; as an unapproved drug it falls under S0 (prohibited at all times)Checked October 2026

Approval status

Not approved anywhere. Ireland's HPRA says no medicines regulator has authorised it. Australia's TGA says it is not approved and is illegal to supply without a prescription. In 2007 the FDA warned a US seller that it could not be sold without approval; its former owner and staff later pleaded guilty. FDA lists safety risks from published case reports.34678

What it’s used or studied for

  • Human studies

    Skin tanning without sun: a small 1990s pilot study in three healthy men found it darkened the skin.2

  • Human studies

    Erectile dysfunction: two small placebo-controlled trials in men found it caused erections. A close variant, bremelanotide (PT-141), was developed for sexual function.91011

Each label shows how strong the evidence is: an approved use, human studies, animal or lab studies only, or a popular claim with no published studies. Being studied is not the same as being proven safe or effective.

Side effects

Common

  • Nausea
  • Vomiting
  • Facial flushing
  • Headache
  • Loss of appetite
  • Stretching and yawning
  • Spontaneous erections
  • Drowsiness and tiredness

Serious or rare

  • Melanoma, reported in users in case reports
  • New moles or rapidly changing moles
  • Priapism (a painful erection lasting hours)
  • Rhabdomyolysis (muscle breakdown) with kidney injury
  • Kidney infarction (one case report)
  • Brain swelling (posterior reversible encephalopathy syndrome)

Common effects come from small 1990s trials and Australia's TGA. Serious effects come from case reports and regulator warnings. Ireland's HPRA also lists vision loss, stroke, muscle tremors and anaphylaxis among reported effects.2347911121314151617

Cautions

  • Products are unregulated. Regulators say buyers cannot know what they contain, and seized nasal sprays varied in strength between bottles.45
  • Sharing needles can spread blood-borne viruses such as HIV and hepatitis; the UK MHRA has warned about this and about impure products.18
  • It does not protect skin from sun damage. Australia's TGA says sunscreen is still needed.4
  • Regulators advise anyone using it to stop and to see a doctor about concerns, such as new or changing moles.34

Sources

  1. PubChem: Melanotan II (CID 92432)
  2. Dorr RT et al. Evaluation of melanotan-II in a pilot phase I clinical study. Life Sci 1996
  3. HPRA (Ireland): HPRA highlights serious health risk of Melanotan 2 self-tan products (2022)
  4. TGA (Australia): Melanotan tanning products
  5. TGA (Australia): Warning about Melanotan II nasal spray tanning products (2026)
  6. US Department of Justice: Guilty pleas after sales of unapproved Melanotan II despite a 2007 FDA warning letter (2015)
  7. FDA: Bulk drug substances used in compounding that may present significant safety risks
  8. WADA: 2026 Prohibited List
  9. Wessells H et al. Melanotan-II initiates erections in men with psychogenic erectile dysfunction. J Urol 1998
  10. Wessells H et al. Melanotan II, penile erection and sexual desire in men with organic erectile dysfunction. Urology 2000
  11. Nelson ME et al. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis. Clin Toxicol 2012
  12. Habbema L et al. Risks of unregulated use of alpha-MSH analogues: a review. Int J Dermatol 2017
  13. Hjuler KF, Lorentzen HF. Melanoma associated with the use of melanotan-II. Dermatology 2014
  14. Yassin Alsabbagh A et al. Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma? Int J Oral Maxillofac Surg 2025
  15. Mallory CW et al. Melanotan tanning injection: a rare cause of priapism. Sex Med 2021
  16. Dreyer BA et al. Melanotan-induced priapism: a hard-earned tan. BMJ Case Rep 2019
  17. Peters B et al. Melanotan II: a possible cause of renal infarction. CEN Case Rep 2020
  18. Langan EA et al. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'? Br J Dermatol 2010 (review)

Spotted a mistake on this page? Report it. The email opens with the peptide and vial already filled in.